Spectrum Formulation Private Limited

Spectrum Formulation Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U74140MP2005PTC017577 Incorporated 05 May 2005 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹42.18 Cr
▲ 23% YoY
Net loss · FY 2025
₹26.58 Cr
Net margin -63%
EBITDA · FY 2025
-₹24.9 Cr
EBITDA margin -59%
Authorised capital
₹1.2 Cr
Registered with MCA
Paid-up capital
₹1.2 Cr
Issued & subscribed
Open charges
₹9.42 Cr
Satisfied ₹7.62 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
30
Provident fund records

About Spectrum Formulation Private Limited

Data last updated:

Spectrum Formulation Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 May 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U74140MP2005PTC017577. Its GSTIN is 05AAJCS3565N1ZU (Uttarakhand).

The company has an authorised share capital of ₹1.2 Cr and a paid-up capital of ₹1.2 Cr. It was formerly known as Visharad Distibutor Private Limited. It is led by directors including Harsh Aggarwal and Shubham Gupta.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indore, Madhya Pradesh.

As per the financials filed for FY 2025, the company reported a revenue of ₹42.18 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net loss of ₹26.58 Cr (net margin -63%) and EBITDA of -₹24.9 Cr (EBITDA margin -59%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 40% over five years.

The company has about 30 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Spectrum Formulation. As per MCA filings, the company has open charges of ₹9.42 Cr and satisfied charges of ₹7.62 Cr on record. Court records list 22 cases involving the company, including 7 filed by the company and 15 filed against it; 10 cases are pending.

Spectrum Formulation Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0003877). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74140MP2005PTC017577
Registration Number 017577
Incorporation Date 05 May 2005
ROC Gwalior
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-06-0003877

Name history

Spectrum Formulation has undergone 3 name changes throughout its history. The company was previously known as Visharad Distibutor Private Limited, Spectrum Formulation Private Limited, and Visharad Formulation Private Limited. The current legal name is Spectrum Formulation Private Limited.

Company NameStatus
Spectrum Formulation Private LimitedCurrent
Visharad Distibutor Private LimitedPrevious
Visharad Formulation Private LimitedPrevious

Recognitions & Rankings of Spectrum Formulation

MSME (Udyam registered) Ministry of MSME
Category
Small (2020-21)
Udyam number
UDYAM-UK-06-0003877

Contact details

Spectrum Formulation Private Limited's registered office is in Indore, Madhya Pradesh. Its website is 9997680999. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Registered Address
    Office No. 305 3rd Floor Satguru Parinay, 5Pu – 3 Scheme No 54 A.B. Road, Indore, Madhya Pradesh, India – 452010
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Spectrum Formulation Private Limited, buy the company report.

Comprehensive company report
Spectrum Formulation Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Spectrum Formulation operates one associated brand: Spectrum Formulation. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturing, supplying, and distributing pharmaceutical products in India.spectrumformulation.com

Business activity

The main business activity of Spectrum Formulation is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Spectrum Formulation Private Limited, buy the company report.

Financials of Spectrum Formulation Private Limited

FY 2025 filings available

Spectrum Formulation Private Limited reported revenue of ₹42.18 Cr (up 23% YoY) for FY 2025.

Revenue · FY 2025
₹42.18 Cr ▲ 23%
Net loss · FY 2025
₹26.58 Cr margin -63%
EBITDA · FY 2025
-₹24.9 Cr margin -59%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 21%
5 years · compounded
▲ 40%

Revenue has grown at a compounded annual rate (CAGR) of 40% over five years, including 23% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations₹42.18 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹24.9 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹26.58 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-59%
Net Profit Margin-63%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Spectrum Formulation Private Limited, buy the company report.

Board of directors of Spectrum Formulation Private Limited

Spectrum Formulation has 3 current directors and 21 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Harsh AggarwalDirector11 Nov 20224 Years 0 MonthsCurrent
Shubham GuptaDirector03 Jan 20233 Years 10 MonthsCurrent
Anurag AggarwalDirector11 Nov 20224 Years 0 MonthsCurrent

Peer comparison

Spectrum Formulation Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Legency Remedies Private Limited₹42.77 Cr (FY 2025)-11.0%Baddi, Himachal Pradesh, India
Brussels Laboratories Pvt Ltd₹42.73 Cr (FY 2025)7.0%Dist-Ahmedabad, Gujarat, India
La Chemico Pvt Ltd₹42.52 Cr (FY 2024)0.0%Kolkata, West Bengal, India
Maya Biotech Private Limited₹42.5 Cr (FY 2024)-3.0%Chandigarh, India
Base Medico Private Limited₹42.21 Cr (FY 2025)-12.0%Vadodara, Gujarat, India
Spectrum Formulation Private Limitedthis company₹42.18 Cr (FY 2025)-₹26.58 Cr-63%23.0%30Indore, Madhya Pradesh, India
Supercure Biotech Private Limited₹42.03 Cr (FY 2024)6.0%Delhi, India
International Ingredients & Excipients Private Limited₹41.96 Cr (FY 2025)58.0%Chennai, Tamil Nadu, India
Samrudh Pharmacare Private Limited₹41.88 Cr (FY 2024)-7.0%Mumbai, Maharashtra, India
Aap Pharma Technologies India Private Limited₹41.83 Cr (FY 2024)-13.0%Hyderabad, Telangana, India

To see the full peer comparison of Spectrum Formulation Private Limited, buy the company report.

Auditor

Spectrum Formulation Private Limited is audited by R. Tayal & Associates for the financial year 2024.

Auditor firmFinancial yearFirm registration number
R. Tayal & AssociatesFY 2024006969N

Shareholding

The shareholding of Spectrum Formulation Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2025FY 2024FY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Spectrum Formulation Private Limited, buy the company report.

Charges & borrowings

Open charges
₹9.42 Cr
Satisfied charges
₹7.62 Cr
Breakdown by lending institutions
Axis Bank Limited₹9.42 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
31 Dec 2024101048914Axis Bank Limited₹2.2 CrOpen
15 May 2024100926877Axis Bank Limited₹2.7 CrOpen
28 May 2021100449217Axis Bank Limited₹4.52 CrOpen
28 May 2021100449219Axis Bank Limited₹50 LakhSatisfied
28 May 2021100449852Axis Bank Limited₹31.07 LakhSatisfied

To see the full charge records of Spectrum Formulation Private Limited, buy the company report.

Total charge records: 11 View all charges

MSME payment delays

Spectrum Formulation Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 442 overdue payments to 32 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 32)

SupplierAmount dueDue sinceReported on
an individual supplier
an individual supplier
an individual supplier
Radiant Printo Pack
Garud Industries

To see the full MSME payment records of Spectrum Formulation Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Spectrum Formulation Private Limited has a workforce of 30 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
30
Active EPFO establishments
1
Employee growth
-9.1%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2730
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20

To see the full employee and EPFO history of Spectrum Formulation Private Limited, buy the company report.

GST

Spectrum Formulation has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
05AAJCS3565N1ZUUttarakhandActive01 Jul 2017

To see the full GST registrations and return filing status of Spectrum Formulation Private Limited, buy the company report.

Recent activity

Spectrum Formulation Private Limited has 25 board changes on record since 2009: 4 appointments and 21 cessations. The latest: Aman Aggarwal ceased to be Additional Director on 29 Sep 2023.

AGM
Spectrum Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Spectrum Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge registered on 28 May 2021 via Charge ID 100449219 with Axis Bank Limited was fully satisfied on 09 Jan 2025.
Charges
A charge registered on 28 May 2021 via Charge ID 100449852 with Axis Bank Limited was fully satisfied on 09 Jan 2025.
Charges
A charge with Axis Bank Limited amounted to Rs. 2.20 Cr with Charge ID 101048914 was registered on 31 Dec 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 2.70 Cr with Charge ID 100926877 was registered on 15 May 2024.
Charges
A charge with Axis Bank Limited of Rs. 4.52 Cr registered on 28 May 2021 with Charge ID 100449217 was modified on 15 May 2024.
Charges
A charge registered on 04 Sep 2020 via Charge ID 100371426 with Others was fully satisfied on 04 Oct 2023.
Charges
A charge registered on 29 Jun 2017 via Charge ID 100112610 with Others was fully satisfied on 04 Oct 2023.
Charges
A charge registered on 29 Jun 2017 via Charge ID 100112626 with Others was fully satisfied on 04 Oct 2023.
Ceased
Aman Aggarwal ceased to be Additional Director.
Ceased
Anurag Aggarwal ceased to be Additional Director.

39 earlier events are in the company report.

Frequently asked questions

Spectrum Formulation is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 May 2005 (21+ years old) and is registered under CIN U74140MP2005PTC017577.

Spectrum Formulation has 3 current directors:

The latest financial statements of Spectrum Formulation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Spectrum Formulation is 05AAJCS3565N1ZU, registered in Uttarakhand.

The CIN (Corporate Identification Number) of Spectrum Formulation is U74140MP2005PTC017577. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Spectrum Formulation has 22 court cases on record: 7 filed by the company and 15 filed against it. 10 are pending. Most are in the district courts.

Spectrum Formulation was incorporated on 05 May 2005, making it 21+ years old. It is registered with the Registrar of Companies, Gwalior.

The peers of Spectrum Formulation by revenue are Legency Remedies Private Limited, Brussels Laboratories Pvt Ltd, La Chemico Pvt Ltd, Maya Biotech Private Limited, Base Medico Private Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Aman Aggarwal ceased to be Additional Director on 29 Sep 2023. Anurag Aggarwal ceased to be Additional Director on 29 Sep 2023. Harsh Aggarwal ceased to be Additional Director on 29 Sep 2023. Spectrum Formulation has 25 board changes on record in total.

Yes, Spectrum Formulation is registered as a small enterprise under Udyam registration (number: UDYAM-UK-06-0003877).

Spectrum Formulation has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 442 overdue payments to 32 micro and small suppliers. The latest return was filed on 30 Apr 2024.

The registered office of Spectrum Formulation is at Office No. 305 3rd Floor Satguru Parinay, 5Pu – 3 Scheme No 54 A.B. Road, Indore, Madhya Pradesh, India – 452010.